Digest Network Come funziona
Network
/
Società
Ad
Non verificato

Aditxt, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieOncologiaSalute

62 comunicati stampa

Guarda tutti i comunicati
09/06/2026
Mercato del lavoro
Mercato azionario
Titoli e azioni
Biotecnologia
Farmaceutica
Salute
Oncologia
Aditxt Signed Definitive Agreement Valuing Ignite Proteomics at Approximately $150 Million
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
01/06/2026
Biotecnologia
Farmaceutica
Salute
Oncologia
Mercato del lavoro
Aditxt, Inc. Appoints Jeffrey M. Busch as Interim Chief Executive Officer; Founder and Former CEO of $1B NYSE Enterprise Which Delivered ~8.5% Dividends to Shareholders
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
14/05/2026
Finanza
Biotecnologia
Salute
Farmaceutica
Oncologia
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-27 Reverse Stock Split Effective at the Open of Trading on May 18, 2026
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
20/04/2026
Industria
Oncologia
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Dana-Farber Cancer Institute Study Demonstrates Predictive Value of Ignite Proteomics’ RPPA Platform for T-DXd (Enhertu®) Therapy in Metastatic Breast Cancer Patients
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
19/03/2026
Scienza
Biotecnologia
Medicina - Varie
Farmaceutica
Salute
Oncologia
Mercato del lavoro
Aditxt Subsidiary Ignite Proteomics Appoints Public Company Veteran Jeff Busch as Chief Executive Officer
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
13/03/2026
Eventi
Mercato azionario
Scienza
Biotecnologia
Medicina - Varie
Farmaceutica
Salute
Oncologia
Aditxt Acquires Ignite Proteomics to Address a Critical Challenge in Cancer Care: Optimizing Therapy Selection
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
05/03/2026
Finanza
Scienza
Biotecnologia
Farmaceutica
Oncologia
Salute
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-8 Reverse Stock Split Effective at the Open of Trading on March 9, 2026
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
18/11/2025
Tecnica
Salute
Finanza
Sanità
Associazioni/Professionisti
Oncologia
Scienza
Software
Titoli e azioni
Aditxt Provides Updates on its Growth Vision for bitXbio™, Planned Digital Asset Treasury, Pearsanta’s Planned IPO, And Evofem’s Plan to Regain a National Listing
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
29/10/2025
Salute
Scienza
Farmaceutica
Biotecnologia
Finanza
Aditxt, Inc. (NASDAQ: ADTX) Announces 1-for-113 Reverse Stock Split Effective at the Open of Trading on November 3, 2025
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0
27/10/2025
Sanità
Vetrine/Shopping
Salute
Medicina - Varie
Industria
Aditxt Subsidiary Pearsanta Begins Enrollment in First Human Study of Blood-Based Diagnostic for Endometriosis, a Condition Affecting 190 Million Women Worldwide and Representing a $1.45 Billion Global Market
Fonte
Aditxt, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0